Safety and Efficacy of AL-15469A 0.5% / AL-6515 0.3% Ophthalmic Suspension for Treatment of Bacterial Conjunctivitis

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

January 31, 2011

Primary Completion Date

December 31, 2011

Conditions

Bacterial Conjunctivitis

Interventions

DRUG

AL-15469A 0.5% and AL-6515 0.3% Ophthalmic Suspension

Topical ocular dosed 3 times per day for 3 days

DRUG

AL-15469A 0.5%

Topical ocular dosed 3 times per day for 3 days

DRUG

AL-6515 0.3%

Topical ocular dosed 3 times per day for 3 days

DRUG

Vehicle

Topical ocular dosed 3 times per day for 3 days